Allovir, Inc. Files 8-K: Officer Departures, Director Elections
Ticker: KLRS · Form: 8-K · Filed: Mar 12, 2025 · CIK: 1754068
| Field | Detail |
|---|---|
| Company | Allovir, Inc. (KLRS) |
| Form Type | 8-K |
| Filed Date | Mar 12, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, personnel-change, filing
TL;DR
Allovir's leadership is changing: officers out, new directors in, and comp plans updated. Big governance shakeup.
AI Summary
On March 12, 2025, Allovir, Inc. filed an 8-K report detailing several key events. The company announced the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for its officers. Additionally, the filing covers the submission of matters to a vote of security holders and other events not previously disclosed.
Why It Matters
This filing indicates significant changes in Allovir's leadership and governance structure, which could impact the company's strategic direction and operational stability.
Risk Assessment
Risk Level: medium — Changes in key personnel and governance can introduce uncertainty and potential strategic shifts, impacting investor confidence.
Key Players & Entities
- Allovir, Inc. (company) — Registrant
- March 12, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-39409 (filing_number) — SEC File Number
- 83-1971007 (tax_id) — I.R.S. Employer Identification No.
- ViraCyte, Inc. (company) — Former Company Name
- 20180924 (date) — Date of Name Change
FAQ
Who has departed from Allovir, Inc. as reported in the 8-K?
The 8-K filing indicates the departure of certain officers and directors.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported is dated March 12, 2025.
What specific items are covered under 'ITEM INFORMATION' in this filing?
The filing covers 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers', 'Submission of Matters to a Vote of Security Holders', 'Other Events', and 'Financial Statements and Exhibits'.
What was Allovir, Inc.'s former company name?
Allovir, Inc.'s former company name was ViraCyte, Inc.
In which state was Allovir, Inc. incorporated?
Allovir, Inc. was incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 12, 2025 regarding Allovir, Inc. (KLRS).